A narrative review of cost-effectiveness analysis of people living with HIV treated with HAART: from interventions to outcomes

BACKGROUND: Since its introduction in 1996, highly active antiretroviral therapy (HAART), which involves the combination of antiretroviral drugs, has resulted in significant improvements in the morbidity, mortality, and life expectancy of HIV-infected patients. Numerous studies of the cost-effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Tse, Wah Fung, Yang, Weimin, Huang, Wenlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540173/
https://www.ncbi.nlm.nih.gov/pubmed/26316787
http://dx.doi.org/10.2147/CEOR.S85535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540173/
https://www.ncbi.nlm.nih.gov/pubmed/26316787
http://dx.doi.org/10.2147/CEOR.S85535

Ejemplares similares